Page Updated: Tuesday, November 18, 2025 11:03 PM ET

CNBC - Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

12 hours ago

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform

12 hours ago

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

1 day ago

Congress hemp ban raises fears of mass layoffs and black market growth

1 day ago

U.S. employer health plans tap prescriptions that feds say are illegal

5 days ago

Healthy Returns: Novo Nordisk boosts the case for its obesity pill with new data

5 days ago

Rocket Lab posts record third-quarter revenue, launch backlog

7 days ago

Trump tells Republicans to send health insurance money 'directly to the people'

7 days ago

Trump's deals with Eli Lilly, Novo Nordisk could broaden obesity drug access

10 days ago

Startup Omada Health to start prescribing GLP-1s, other obesity medications

11 days ago

Here's how much weight loss drugs could cost under Trump's deals with Lilly, Novo

12 days ago

Trump announces deal with Eli Lilly, Novo Nordisk to cut weight loss drug prices

12 days ago

Eli Lilly to start late-stage trials on amylin obesity drug after promising data

12 days ago

Healthy Returns: Pfizer, Novo Nordisk escalate bidding war over Metsera

12 days ago

Metsera says Novo Nordisk's new bid is 'superior' to revised Pfizer offer

13 days ago

Pfizer tops estimates, raises profit guidance even as sales fall

14 days ago

Pfizer files second lawsuit against Novo Nordisk, Metsera in obesity bidding war

14 days ago

Where the blockbuster weight loss drug market stands today — and what's coming next

16 days ago

'Trump effect' raises hopes for cannabis rally as investors bet on change

16 days ago

Breast cancer drug stock Olema Pharmaceutical could more than double from here

17 days ago

This biotech stock has jumped 50% in 3 months

19 days ago

We're raising our Eli Lilly price target — what a difference a quarter makes

19 days ago

Midi Health introducing testosterone therapy as demand from women spikes

19 days ago

Eli Lilly blows past estimates, hikes guidance on Zepbound and Mounjaro sales

19 days ago

Merck tops estimates on Keytruda strength and narrows profit outlook

19 days ago

FDA to speed up approvals of biosimilars as Trump targets high drug costs

19 days ago

Eli Lilly, Walmart to offer discounted retail option for obesity drug Zepbound

20 days ago

CVS beats estimates, hikes guidance as insurance business improves

20 days ago

Eli Lilly, Nvidia to build supercomputer, AI factory for drug discovery

20 days ago

Healthy Returns: What to expect from Eli Lilly, Merck, AbbVie Q3 earnings

21 days ago

Novartis CEO says firm has the firepower for big M&A deals: 'Can never be done'

21 days ago

Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill

28 days ago

Why cattlemen say Trump Argentine beef import idea no solution for record prices

28 days ago

Novo Nordisk chair and directors quit after boardroom rift

28 days ago